Literature DB >> 20079588

Long-term health issues of women with XY karyotype.

Marta Berra1, Lih-Mei Liao, Sarah M Creighton, Gerard S Conway.   

Abstract

46XY women is a label that gathers together a number of different conditions for which the natural history in to adult life is still only partially known. A common feature is the difficulty that many women encounter when approaching clinicians. In this review we assemble medical, surgical and psychological literature pertaining adult 46XY women together with our experience gained from an adult DSD clinic. There is increasing awareness for the need for multidisciplinary team involving endocrinologist, gynaecology, nurse specialist and particularly clinical psychologists. Management of adult women with a 46XY karyotype includes several aspects: revising the diagnosis in those with previously incomplete workup; exploring issues of disclosure of details of the diagnosis. Surgery needs to be discussed when the gonads are still in situ and when partial virilisation of genitalia have occurred. To maintain secondary sexual characteristics, for general well being and for bone health, most women require sex steroid replacement continuously until the approximately age of 50 and it is important that the treatment is tailored on individual basis. Women should have access to advice about fertility options involving egg donation and surrogacy. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20079588     DOI: 10.1016/j.maturitas.2009.12.004

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  4 in total

Review 1.  Transition of care for adolescents with disorders of sex development.

Authors:  Naomi S Crouch; Sarah M Creighton
Journal:  Nat Rev Endocrinol       Date:  2014-05-20       Impact factor: 43.330

2.  Complete gonadal dysgenesis analysis in the population of Latvia: malignant outcomes and a review of literature.

Authors:  Alise Jakovleva; Zanna Kovalova
Journal:  Med Pharm Rep       Date:  2022-01-31

Review 3.  Risks in Surrogacy Considering the Embryo: From the Preimplantation to the Gestational and Neonatal Period.

Authors:  M Simopoulou; K Sfakianoudis; P Tsioulou; A Rapani; G Anifandis; A Pantou; S Bolaris; P Bakas; E Deligeoroglou; K Pantos; M Koutsilieris
Journal:  Biomed Res Int       Date:  2018-07-17       Impact factor: 3.411

Review 4.  Caring for individuals with a difference of sex development (DSD): a Consensus Statement.

Authors:  Martine Cools; Anna Nordenström; Ralitsa Robeva; Joanne Hall; Puck Westerveld; Christa Flück; Birgit Köhler; Marta Berra; Alexander Springer; Katinka Schweizer; Vickie Pasterski
Journal:  Nat Rev Endocrinol       Date:  2018-07       Impact factor: 43.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.